Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Event is part of the PGA TOUR's Women's Initiative, sponsored by Astellas, and is expected to attract more than 200 female leaders PITTSBURGH, Pa, and NORTHBROOK, Ill., June 25, 2013 /PRNewswire/...
On-course Women's Pavilion also at tournament as part of the PGA TOUR's Women's Initiative, sponsored by Astellas BETHESDA, Md., and NORTHBROOK, Ill., June 24, 2013 /PRNewswire/ -- The PGA TOUR...
NORTHBROOK, Ill., June 24, 2013 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced that the U.S. Food and Drug...
NORTHBROOK, IL – June 20, 2013 – Astellas US LLC (“Astellas”) was named one of the 100 top organizations honored in IDG's Computerworld 2013 Best Places to Work in IT. Astellas was the...
NORTHBROOK, Ill., June 5, 2013 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that the company has entered...
On-course Women's Pavilion also at tournament as part of the PGA TOUR's Women's Initiative, sponsored by Astellas MEMPHIS, Tenn. and NORTHBROOK, Ill., June 4, 2013 /PRNewswire/ -- The PGA TOUR and...
NORTHBROOK, Ill., May 28, 2013 – Astellas Pharma US, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that Margaret Long has been promoted to Vice President...
Read more about Astellas US Promotes Two Leaders in Government Affairs
On-course Women's Pavilion also at tournament as part of the PGA TOUR's Women's Initiative, sponsored by Astellas FORT WORTH, Texas and NORTHBROOK, Ill., May 21, 2013 /PRNewswire/ -- The PGA TOUR...
Tarceva is the First Personalized Medicine Approved for the Initial Treatment of People with EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer in the United States SOUTH SAN FRANCISCO,...
SAN DIEGO, May 7, 2013 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that results of three studies of...
Follow U.S. news
